Elanco Financial Statements From 2010 to 2026

ELAN Stock  USD 26.19  0.65  2.42%   
Elanco Animal's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Elanco Animal's valuation are provided below:
Gross Profit
2.6 B
Profit Margin
(0.05)
Market Capitalization
13.3 B
Enterprise Value Revenue
3.0865
Revenue
4.7 B
We have found one hundred twenty available fundamental signals for Elanco Animal Health, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to verify Elanco Animal's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Elanco Animal Total Revenue

4.09 Billion

Check Elanco Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elanco Animal's main balance sheet or income statement drivers, such as Tax Provision of 181.1 M, Depreciation And Amortization of 537.1 M or Interest Expense of 162.1 M, as well as many indicators such as Price To Sales Ratio of 3.38, Dividend Yield of 0.0 or PTB Ratio of 1.71. Elanco financial statements analysis is a perfect complement when working with Elanco Animal Valuation or Volatility modules.
  
Build AI portfolio with Elanco Stock
Check out the analysis of Elanco Animal Correlation against competitors.

Elanco Animal Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding465.6 M496.4 M406 M
Slightly volatile
Total Assets13.7 B13.4 B11 B
Slightly volatile
Other Current Liabilities886.6 M1.2 B661.5 M
Slightly volatile
Total Current Liabilities1.4 B1.6 BB
Slightly volatile
Total Stockholder Equity5.4 B6.5 B6.8 B
Slightly volatile
Other Liabilities780.6 M1.1 B672.3 M
Slightly volatile
Property Plant And Equipment Net1.1 B1.4 B936.8 M
Slightly volatile
Accounts Payable341.1 M368 M283 M
Slightly volatile
Cash465.7 M545 M367.8 M
Slightly volatile
Non Current Assets Total10.6 B9.9 B8.4 B
Slightly volatile
Non Currrent Assets Other308.7 M304 M255.2 M
Slightly volatile
Other Assets123.4 M173.7 M175.7 M
Slightly volatile
Cash And Short Term Investments465.7 M545 M367.8 M
Slightly volatile
Net Receivables965.2 M940 M795.5 M
Slightly volatile
Good Will4.9 B4.8 B3.8 B
Slightly volatile
Liabilities And Stockholders Equity13.7 B13.4 B11 B
Slightly volatile
Non Current Liabilities Total4.9 B5.2 B3.1 B
Slightly volatile
Inventory1.5 B1.7 B1.2 B
Slightly volatile
Other Current Assets271.1 M236 M225.3 M
Slightly volatile
Other Stockholder Equity7.8 B8.9 B7.3 B
Pretty Stable
Total Liabilities6.3 B6.8 B4.1 B
Slightly volatile
Long Term Investments15.9 M24.3 M15.1 M
Slightly volatile
Property Plant And Equipment Gross1.5 B2.1 B1.2 B
Slightly volatile
Total Current Assets3.2 B3.5 B2.6 B
Slightly volatile
Non Current Liabilities Other243.3 M347.3 M191.2 M
Slightly volatile
Intangible Assets4.2 B3.4 B3.4 B
Slightly volatile
Common Stock8.5 B9.3 B7.9 B
Slightly volatile
Property Plant Equipment1.1 B1.1 B934.4 M
Slightly volatile
Net Invested Capital12 B12 B9.8 B
Slightly volatile
Net Working Capital1.8 B2.2 B1.6 B
Slightly volatile
Short and Long Term Debt Total5.1 BB3.7 B
Slightly volatile
Current Deferred Revenue632.7 M602.6 M386.2 M
Slightly volatile
Long Term DebtB4.9 B3.6 B
Slightly volatile
Long Term Debt Total1.9 B2.1 B2.4 B
Slightly volatile
Capital Surpluse8.2 B10 B6.8 B
Slightly volatile
Short and Long Term Debt37.6 M39.6 M98.9 M
Slightly volatile
Short Term Debt144.7 M74 M107.2 M
Slightly volatile
Short Term Investments11.2 M12.6 M13.8 M
Slightly volatile

Elanco Animal Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization537.1 M680 M417.2 M
Slightly volatile
Selling General AdministrativeB1.2 B951.7 M
Slightly volatile
Total Revenue4.1 B4.7 B3.5 B
Slightly volatile
Gross Profit1.8 BB1.5 B
Slightly volatile
Other Operating Expenses3.8 B4.5 B3.3 B
Slightly volatile
Research Development338.1 M368 M304.4 M
Slightly volatile
Cost Of Revenue2.3 B2.7 BB
Slightly volatile
Total Operating Expenses1.5 B1.8 B1.3 B
Slightly volatile
Reconciled Depreciation533.9 M761.3 M435.7 M
Slightly volatile
Extraordinary Items26.5 M29.8 M32.5 M
Slightly volatile
Interest Income59.7 M90.7 M52.4 M
Slightly volatile
Non Recurring384.8 M210.4 M220 M
Slightly volatile
Selling And Marketing Expenses302.1 M212.4 M727.2 M
Slightly volatile

Elanco Animal Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation47.5 M68 M34.7 M
Slightly volatile
Begin Period Cash Flow449 M468 M324.7 M
Slightly volatile
Depreciation537.1 M680 M417.2 M
Slightly volatile
Capital Expenditures191 M276 M153 M
Slightly volatile
End Period Cash Flow491.9 M545 M453.7 M
Pretty Stable
Sale Purchase Of Stock1.2 B1.1 B1.4 B
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.382.38253.4831
Slightly volatile
PTB Ratio1.711.71581.6543
Slightly volatile
Days Sales Outstanding94.1772.767883.7857
Pretty Stable
Book Value Per Share17.713.18917.4702
Slightly volatile
Stock Based Compensation To Revenue0.0090.01440.0092
Slightly volatile
Capex To Depreciation0.430.40590.3992
Slightly volatile
PB Ratio1.711.71581.6543
Slightly volatile
EV To Sales4.133.11893.9699
Slightly volatile
Inventory Turnover1.781.53431.6929
Slightly volatile
Days Of Inventory On Hand183238217
Slightly volatile
Payables Turnover5.867.24187.0945
Very volatile
Sales General And Administrative To Revenue0.190.220.2372
Slightly volatile
Research And Ddevelopement To Revenue0.09260.0780.0894
Slightly volatile
Capex To Revenue0.03780.05850.0429
Slightly volatile
Cash Per Share1.11.09790.9065
Slightly volatile
Days Payables Outstanding57.7450.401552.8835
Very volatile
Intangibles To Total Assets0.520.61290.6414
Pretty Stable
Current Ratio2.742.16532.7363
Slightly volatile
Receivables Turnover3.55.0164.405
Pretty Stable
Shareholders Equity Per Share17.713.18917.4702
Slightly volatile
Debt To Equity0.550.61360.5806
Slightly volatile
Capex Per Share0.330.5560.3658
Slightly volatile
Revenue Per Share7.09.49848.475
Pretty Stable
Interest Debt Per Share8.58.53559.2563
Slightly volatile
Debt To Assets0.270.30070.304
Slightly volatile
Graham Number8.4812.411.1137
Slightly volatile
Operating Cycle251311299
Pretty Stable
Price Book Value Ratio1.711.71581.6543
Slightly volatile
Days Of Payables Outstanding57.7450.401552.8835
Very volatile
Company Equity Multiplier1.482.04031.5802
Slightly volatile
Long Term Debt To Capitalization0.310.37590.3542
Slightly volatile
Total Debt To Capitalization0.320.38030.3598
Slightly volatile
Debt Equity Ratio0.550.61360.5806
Slightly volatile
Quick Ratio1.461.07761.4799
Slightly volatile
Net Income Per E B T1.141.03570.9786
Very volatile
Cash Ratio0.40.34130.385
Slightly volatile
Cash Conversion Cycle209260247
Slightly volatile
Days Of Inventory Outstanding183238217
Slightly volatile
Days Of Sales Outstanding94.1772.767883.7857
Pretty Stable
Price To Book Ratio1.711.71581.6543
Slightly volatile
Fixed Asset Turnover2.973.34633.746
Pretty Stable
Debt Ratio0.270.30070.304
Slightly volatile
Price Sales Ratio3.382.38253.4831
Slightly volatile
Asset Turnover0.340.3530.3316
Slightly volatile
Gross Profit Margin0.340.43480.4206
Very volatile
Price Fair Value1.711.71581.6543
Slightly volatile

Elanco Fundamental Market Drivers

Forward Price Earnings20.5339
Cash And Short Term Investments545 M

Elanco Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Elanco Animal Financial Statements

Elanco Animal investors utilize fundamental indicators, such as revenue or net income, to predict how Elanco Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue602.6 M632.7 M
Total Revenue4.7 B4.1 B
Cost Of Revenue2.7 B2.3 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.22  0.19 
Research And Ddevelopement To Revenue 0.08  0.09 
Capex To Revenue 0.06  0.04 
Revenue Per Share 9.50  7.00 
Ebit Per Revenue 0.05  0.05 

Pair Trading with Elanco Animal

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elanco Animal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elanco Animal will appreciate offsetting losses from the drop in the long position's value.

Moving together with Elanco Stock

  0.73AMG Amgen IncPairCorr

Moving against Elanco Stock

  0.721P Aurora CannabisPairCorr
  0.65P52 NEWBURY PHARMACEUTICALSPairCorr
  0.46VRCA Verrica PharmaceuticalsPairCorr
  0.42WEED Canopy Growth CorpPairCorr
  0.35BSFA ANI Pharmaceuticals Earnings Call TodayPairCorr
The ability to find closely correlated positions to Elanco Animal could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elanco Animal when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elanco Animal - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elanco Animal Health to buy it.
The correlation of Elanco Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elanco Animal moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elanco Animal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elanco Animal can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock:
Check out the analysis of Elanco Animal Correlation against competitors.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Will Pharmaceuticals sector continue expanding? Could Elanco diversify its offerings? Factors like these will boost the valuation of Elanco Animal. Projected growth potential of Elanco fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Elanco Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.167
Earnings Share
0.07
Revenue Per Share
9.498
Quarterly Revenue Growth
0.122
Return On Assets
0.0125
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Elanco Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elanco Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elanco Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.